Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

Title:	Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial
Authors:	Kubasch, A. S.^{Aff1, Aff2, Aff3}; Peterlin, P.^{Aff3, Aff4}; Cluzeau, T.^{Aff3, Aff5}; Götze, K. S.^{Aff2, Aff3, Aff6}; Sockel, K.^{Aff2, Aff7}; Teipel, R.^Aff7; Jentzsch, M.^Aff1; Attalah, H.^Aff8; Sebert, M.^{Aff8, Aff9}; Chermat, F.^Aff8; Gloaguen, S.^{Aff2, Aff3}; Puttrich, M.^Aff10; Cross, M.^Aff1; Schneider, M.^Aff1; Kayser, S.^{Aff11, Aff12}; Schipp, D.^Aff13; Giagounidis, A.^{Aff2, Aff3, Aff14}; Tirado-Gonzalez, I.^Aff15; Descot, A.^Aff15; van de Loosdrecht, A.^{Aff3, Aff16}; Weigert, A.^Aff1; Metzeler, K. H.^Aff1; Fenaux, P.^{Aff3, Aff8, Aff9}; Medyouf, H.^{Aff15, Aff17, Aff18}; Platzbecker, U.^{Aff1, Aff2, Aff3, IDs41375023020291_cor25}; Ades, L.^{Aff3, Aff8, Aff9}
Source:	Leukemia. 37(11):2309-2313
Database:	Springer Nature Journals